Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
2,6-SUBSTITUTED-4-MONOSUBSTITUTEDAMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS

No-Receipt date 2012-03322 - 24/10/2012
No-Filing date 20120402399 - 24/10/2012
No-Granting date 3079223 - 29/10/2012
No-EPO application date 05812481.9 - 14/10/2005
No-EPO granting date 1891019 - 25/07/2012
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2012 - 22/11/2012
Expiration date 15/10/2025
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities US619272 P15/10/2004/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07D 413/04
C07D 409/04
C07D 403/04
C07D 239/46

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
345301 AVENTISUB LLC 3711 KENNETT PIKE, SUITE 200GREENVILLE, DE 19807,U.S.A UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1032986 LIM, SUNGTAEK
1032987 HARRIS, KEITH JOHN
1032988 STEFANY, DAVID
1032989 GARDNER, CHARLES J.
1032990 CAO, BIN
1032991 BOFFEY, RAY ARGENTA DISCOVERY LTD.
1032992 GILLESPY, TIMOTHY A.
1032993 AGUIAR, JOACY, C.
1032994 HUNT, HAZEL J.
1032995 DECHAUX, ELSA A.

Representatives
CodeFirstnameSurnameAddressTownZip
3089NIKOLAOSLYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"STOURNARI 37ATHINA (ATTIKIS)10682

Contact
CodeFirstnameSurnameAddressTownZipCountry
7915NIKOLAOSLYMPERISSTOURNARI 37ATHINA (ATTIKIS)10682 GREECE

Owners History
Date Description Comments Data before modification Data after modification
15/02/2013 Αλλαγή Διεύθυνσης Δικαιούχου (7e800) ΑΡ. ΠΡΩΤ. 666/6-2-2013, ΚΩΔ. ΠΛΗΡ. 3090, ( ΜΕ ΤΗΝ ΥΠ'ΑΡΘ. USAV2003/0043/08.01.2013 ΚΟΙΝΟΠΟΙΗΣΗ ΤΟΥ ΕΓΔΕ) 434817 Aventis Pharmaceuticals Inc. 300 Somerset Corporate Boulevard ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bridgewater, NJ 08807 471513 Aventis Pharmaceuticals Inc. 55 Corporate Drive, ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bridgewater, NJ 08807
19/09/2016 Συγχωνεύσεις Εταιριών (7e803) ΑΡ.ΠΡΩΤ.4594/26-08-16,ΔΝΥ921/14-9-16,ΚΩΔ.ΠΛΗΡ.3190 471513 Aventis Pharmaceuticals Inc. 55 Corporate Drive, ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bridgewater, NJ 08807 345301 Aventisub LLC 3711 Kennett Pike, Suite 200 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Greenville, DE 19807,U.S.A

Title Instruments
DateOperationDescreption
5/4/2018 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 04/2018 Αρ. Πρωτ. ΓΔ 1059 - 04/05/2018

Payments history 12 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015